Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Nigella Sativa Oil as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia

NCT05952102 is registered in ClinicalTrials.gov with Rehab Zaki Elmeazawy as lead sponsor.

NCT NCT05952102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05952102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Nigella Sativa Oil as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia
Lead sponsor
Rehab Zaki Elmeazawy
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2023
Completion date
August 31, 2024
Enrollment
104 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nigella sativa oil as an adjuvant therapy in the treatment of pneumonia